It is widely accepted that the increased availability and use of antibacterial and antifungal agents in recent years has resulted in the control and even eradication of diseases, but it has also ...
UK biotech F2G has raised $100 million as it ... it to complete the late-stage development of olorofim, a novel oral antifungal for invasive aspergillosis and other serious fungal infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback